ArticleBMC plant biology2025
Chromosome-level genome assembly of Ulmus parvifolia identifies genomic signatures and transcriptional profiling underlying Dutch elm disease resistance.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The lack of a high-quality Ulmus parvifolia genome assembly has impeded research on disease resistance and hindered breeding programs for resilient elm cultivars. In this study, we presented a chromosome-level genome assembly of U. parvifolia using integrated sequencing technologies. LTR retrotransposons, predominantly the Ty3/Gypsy Retand subfamily, underwent recent large-scale amplification, potentially contributing to the genome size of U. parvifolia. Phylogenetically, U. parvifolia is sister to a clade containing Moraceae, Cannabaceae, and Urticaceae. Notably, gene families associated with disease resistance and immune response were significantly expanded in U. parvifolia, pointing to an adaptive evolution to various biotic and abiotic stresses. To dissect differential susceptibility to Dutch elm disease, we inoculated U. parvifolia (resistant) and U. americana (susceptible) with Ceratocystis ulmi and performed comparative transcriptomics at 48, 96, and 144 h post-inoculation (hpi). Several plant defense and immune response pathways were markedly upregulated in U. parvifolia at 48/96 hpi, revealing a genetic basis for its enhanced resistance. This study advances genomic resources for elms, elucidates molecular mechanisms of disease resilience, and provides a foundation for breeding and conservation efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.